Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

MCD Cancer > Breast Cancer > Flashcards

Breast Cancer Flashcards

1
Q

what are the changes in breast cancer incidence and mortality?

A

cancer incidence is increasing mortality is falling

1 in 5 cancer deaths in women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the reasons for the changes in breast cancer mortality?

A
  • early diagnosis
  • better treatment:
  • chemo/ radio therapies
  • (endocrine) hormonal therapies
  • TAC, Herceptin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what part of the breast can develop cancer?

A

every part of the glands can have a type of cancer

most originate from the luminal epithelium of the tubules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

describe the structure of breast tissue relevant to cancer formation

A

tubules are surrounded by fatty stromal cells.

tubules are aligned by two layers of epithelium: luminal epithelia and myoepithelia (contractile)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

which cells express oestrogen receptors (ER)?

A

luminal epithelial cells (not all)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the normal response to oestrogen?

A

it stimulates growth via production of growth factors by the luminal cells expressing receptors (not the cells themselves)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the abnormal response to oestrogen seen in breast cancer?

A

Oestrogen seen as a GF:

oestrogen-responsive cells directly respond to oestrogen as a GF and stimulate their own growth.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the precancerous stage in the breast? how is it different to cancer?

A

benign/carcinoma in-situ

there is proliferation of cells but invasion has not occurred so there is still myoepithelium surrounding it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are is the difference between a lobular breast cancer and medullary breast carcinoma?

A

lobular has resemblance of the gland while the medullary has no resemblance

ie. medullary is poorly differentiated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are majority of breast cancers?

A

carcinomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are infiltrating ductal carcinomas?

A

have no special histological features

80% of breast cancers are like this

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how are breast cancer samples stained?

A

Immunohistochemically staining using ABs against the human OR (oestrogen receptor) marking the nucleus as OR is a steroid receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what proportion of cancers are oestrogen positive?

A

> 80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the risk factors for breast cancer?

A

involved lifetime exposure to oestrogens:

  • Early menstruation (age of menarche)
  • Late menopause
  • HRT
  • Contraceptive pills
  • age to full term pregnancy
  • obesity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how is the OR found in the cell?

A

bound to a heatshock protein therefore in a dimer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what property allows oestrogen to bind to the OR?

A

the lipophilic oestrogen can pass the membrane and bind

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what happens when oestrogen binds to the OR?

A

the heatshock protein is displaced and then 2 ORs dimerise
the dimerised ORs can enter the nucleus and bind to oestrogen response elements on the DNA to dimerise them aswell (pull them together)

has a growth factor effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what are some oestrogen regulated genes?

A

o Progesterone receptor (PR).
o Cyclin D1.
o C-myc.
o TGF-alpha

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is done in pre-menopausal women with breast cancer to reduce oestrogen effects?

A

oophorectomy (a third of PreM women respond)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is done in post-menopausal women with breast cancer to reduce oestrogen effects?

A

paradoxically respond to high dose oestrogen therapy

ORs are downregulated as a result of high oestrogen conc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what is the prognosis like in OR+ women?

A

better prognosis as overexpression can be treated with oestrogen withdrawal or antagonism with anti-oestrogens
(70% response in OR+ compared to 10-15% in OR-)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

how is the prognosis for OR+ in men?

A

bad,

androgens drive breast cancer in men

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what are the major treatment options for breast cancer?

A

o Surgery.
o Radiation therapy.
o Chemotherapy.
o Endocrine therapy – the gold-standard or cornerstone treatment:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what is involved in endocrine therapy?

A

 Ovarian suppression.
 Blocking oestrogen production by enzymatic inhibition.
 Inhibition of oestrogen responses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what is ovarian ablation?

A

removal (surgical) of a source of oestrogens i.e. ovaries via oophorectomy or ovarian irradiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

why is ovarian ablation not always favoured?

what is preferred instead?

A

morbidity and irreversibility

suppression techniques are preferred (endocrine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

how can ovarian suppression be mediated?

A

by using Luteinising Hormone Releasing Hormone agonists

these have reversible effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

what effect to LHRH agonists have?

A

binds to pituitary and down regulates LH release (enhancing the -ve FB loop on LH), downregulates LHRH receptors and inhibits ovarian function i.e. oestrogen, FSH and LH production

same process for prostate cancer treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

examples of LHRH agonists

A

Goserelin
Buserelin,
Leuprolide
Triptorelin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

what are some hormonal targets for therapy?

A

 LHRH agonists.
 Aromatase inhibitors – prevent conversion.
 Antioestrogens.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

when is endocrine therapy used?

A

as an adjuvant therapy to eliminate any remaining cancer cells to prevent any secondary tumours forming

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

what is tamoxifen?

A

OR-blocker/ Selective ER modulator (SERM)
competitive inhibitor

high efficacy with low side effects
can be used in metastatic breast cancer in post-menopausal women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

what are anti-oestrogens?

A

structurally similar to oestrogens but can’t be differentiated by the OR and therefore will block the receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

what effect does tamoxifen have on cells?

A

arrests them at G1 so negates oestrogen’s effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

what are the positive of tamoxifen?

A

have oestrogenic effects on the bone and CVS by decreasing risk of osteoporosis and atherosclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

what are the risks with using tamoxifen?

A

increased risk of thromboembolic events and can cause endometrial hyperplasia (cancer possibility).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

what are the normal effects of oestrogen on bone?

A

helps maintain bone

38
Q

what are the normal effects of oestrogen on the CVS?

A

lowers LDL
increases HDL

therefore cardiprotective by preventing atherosclerosis

39
Q

what effect does menopause have on the CVD risk in women?

A

with the decrease in oestrogen, the CVS protective effects are lost and their risk then equals to that of men

40
Q

what are some other drugs that be used to target tissues?

A

 Toremifene = analogue of tamoxifen.
 Faslodex = no oestrogen-like activity but effective at controlling oestrogen-stimulated growth.
 Raloxifene = anti-tumour agent in animals.

41
Q

what does faslodex do?

A

o Pure anti-oestrogen.

o Decreases tumour cell invasion and the stimulation of occult endometrial carcinoma.

42
Q

what effects does raloxifene have?

A

o Oestrogenic in bone.
o No activity in breast or uterus.
o Treats osteoporosis.

arguably better than tamoxifen as it doesn’t mess the uterus and Bress

43
Q

what effect does tamoxifen have on the contralateral breast?

A

Tamoxifen reduces the incidence of contralateral breast cancer by a third.

44
Q

what are the issues with using tamoxifen as prophylaxis?

A

o Endometrial cancer (oestrogenic effects on uterus)
o Stroke.(thromboembolism)
o DVT. (thromboembolism)
o Cataracts.

trials with other drugs and aromatase inhibitors are being done for prevention measures

45
Q

what is the main source of oestrogen in post-menopausal women?

A

the main source of oestrogen is from the CONVERSION of the adrenal hormones androstenedione and testosterone (less) to oestrone rather from the ovaries directly

46
Q

where does androgen conversion to oestrogen take place? what catalyses this reaction?

A

extra-adrenal or peripheral sites – liver, fat and muscle.

aromatase enzyme complex.

47
Q

what makes up the aromatase complex?

A

 Cytochrome P450 haem containing protein.

 Flavoprotein NADPH CYP450 reductase.

48
Q

what are the specific actions of aromatase?

A

o Aromatase catalyses 3 steroid hydroxylations involved in conversion of androstenedione to oestrone.
o Aromatase can also metabolise androstenedione to produce oestrone sulphate (circulates in plasma).

49
Q

what are aromatase inhibitors?

A

block off oestrogen production
two types:
type 1- irreversible
type 2- reversible

50
Q

name a type 1 aromatase inhibitor

A

Exemestane

51
Q

name a type 2 aromatase inhibitor

A

Anastrozole (reversible)

52
Q

what does Exemestane do?

A

competitive antagonist:

Competes with androstenedione and testosterone for binding to aromatase.
Enzyme acts on the inhibitor to create reactive alkylating species which covalently bond the active site of the enzyme so are irreversibly inactivated.

53
Q

what does Anastrozole do?

A

Binds reversibly to aromatase

type 2 aromatase inhibitor

54
Q

what is the main progestin?

A

progesterone

55
Q

what are the use of synthetic progestrone in breast cancer?

A

o Endocrine treatment of uterine and breast cancers with proven antineoplastic properties.
o Metastatic breast cancer as a 2nd or 3rd line therapy (e.g. Megestrol acetate).

56
Q

what occurs with long term endocrine therapy?

A

patients become resistant but therapy is continued as responses don’t fade despite dome regulation of receptors

, additional oestrogen inhibitors are used

57
Q

describe normal breast tissue

A

single layer of myoepithelial cells with normal contact with a basement membrane

58
Q

how does the normal breast tissue structure change into a benign/in-situ carcinoma?

A
  • development of multiple layers
  • originates in terminal duct lobular unit
  • develops into invasive ductal carcinoma or invasive lobular carcinoma
59
Q

what are the 2 types of benign carcinoma of the breast ?

A

invasive ductal carcinoma (80%)

invasive lobular carcinoma (5-15%)

60
Q

what type of carcinoma are most cases?

A

invasive ductal carcinoma

  • show no special histological features
  • easily metastasise to axillary lymph nodes –> poor prognosis
61
Q

which lymph nodes can invasive ductal carcinomas metastasise to?

A

axillary lymph nodes

leads to poor prognosis

62
Q

describe the breast lump

A
  • usually painless (pain in only 10%)
  • firm
  • irregular
  • fixed to surroundings

ductal carcinoma is impalpable

63
Q

what is the presentation of Breast cancer?

A

breast features:

  • breast lump
  • breast shape change (e.g. dimpling, swelling)
  • nipple discharge (possibly bloody)
  • breast/nipple pain
  • nipple inversion or retraction

skin:
- peau d’orange (orange skin)
- redness
- skin tethering
- skin ulceration
- skin texture change

  • axillary lump (lymph node changes)
  • malignancy symptoms [3]
64
Q

what are the symptoms of malignancy of breast tumour?

A
  • weight loss
  • bone pain
  • paraneoplastic syndrome
65
Q

what makes up the triple assessment for breast cancer diagnosis?

A

1) clinical exam
2) imaging
3) tissue diagnosis

66
Q

what imaging [2] is done to assess for breast cancer?

A

1) ultrasound (<35yr)
2) mammogram [xray] (>35yr)
- screening begins after 50

67
Q

what are the tissue sampling used to assess for breast cancer?

A

1) fine needle aspiration
- 4 hours for results to come back

2) core biopsy
- takes a day for results to come back

68
Q

what are the 2 subtypes of cancer based on receptor?

A

oestrogen receptor negative

oestrogen receptor positive

69
Q

which subtype of breast cancer is more prominent?

A

oestrogen receptor positive (80%)

requires endocrine therapy

70
Q

what subtype of oestrogen receptor negative cancer is the main one?

A

Erb2 +ve (aka HER2)
this is a tyrosine kinase receptor

treated with Herceptin e.g. trastuzumab

71
Q

describe the oestrogen receptor

  • type
  • responds to
  • regulates
A
  • intracellular
  • respond to oestrogen (a steroid hormone)
  • regulates genes: Cyclin D, cMyc and progesterone receptor
72
Q

what are the surgical options?

A
  • mastectomy (sometimes prophylactic)
  • lumpectomy
  • reconstructive
  • oophorectomy
73
Q

what is the purpose of an oophorectomy?

A

remove the source of oestrogen

74
Q

how can a oophorectomy be done?

A

surgically or by irradiation

75
Q

what is the setback of an oophorectomy?

A

associated morbidity

irreversibility

76
Q

what is the purpose of endocrine treatment?

A

1) ovarian suppression
2) blocking oestrogen production
3) antagonising oestrogen

77
Q

what is used to suppress the ovaries?

how does it do so?

A
  • use of LHRH (GnRH agonist)
  • causes down regulation of LHRH receptors due to overstimulation
  • this means less LH is produced
  • leads to ovarian supression

think about prostate cancer and how that is androgen dependent like breast cancer is oestrogen dependent : makes use of LHRH agonist as well

78
Q

examples of LHRH agonists used in endocrine therapy

A

goserelin

buserelin

79
Q

how is oestrogen production blocked?

A

using aromatase inhibitors

80
Q

what is the major source of oestrogen in post-menopausal women?

A

the adrenals

81
Q

what do the adrenals produce to lead to oestrogen production?

A

adrenals produce the precursors androstenedione/testosterone

which then is converted to oestrone (oestrogen)

82
Q

what converts androstenedione into oestrogen?

A

aromatase

83
Q

how do type 1 aromatase inhibitors interact with aromatase?

A
  • bind to the active site of aromatase
  • generates a reactive species
  • irreversibly binds to enzyme
84
Q

how do type 2 aromatase inhibitors interact with aromatase?

A
  • bind reversibly to aromatase’s active site
85
Q

what is used to antagonise oestrogen?

A

SERMs
Selective Estrogen Receptor Modulators
- used in third of patients with metastatic disease

also used in osteoporosis as oestrogen has effects on the bone

86
Q

examples of SERMs

A

tamoxifen
raloxifene

N.b. used in osteoporosis aswell

87
Q

what are SERMs?

what effect does it have on the cell?

A

competitive antagonists of oestrogen receptor hence selective estrogen receptor modulators

halts the cell at G1

88
Q

what are the side effects of SERMS?

A
  • hot flushes
  • agonist of endometrium (BUT raloxifene is not)
  • thromboembolic episodes (also risk in osteoporosis treatment)
  • cataracts risk
89
Q

how efficacious are SERMs?

  • recurrence
  • mortality
  • woman (age)
  • contralateral breast
  • overall incidence
A
  • reduces recurrence by nearly half
  • reduces mortality by a third
  • equal in pre- and post-menopausal women
  • reduced contralateral breast cancer by a third
  • overall reduction in incidence (38%)
90
Q

why does the response to oestrogen therapy not fade even though resistance has been developed?

A

the receptor is still expressed so therapy must go on

here, when oestrogen receptor expression is lost, other drugs are considered to be given in addition

MCD Cancer (17 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions